Crispr Therapeutics shares owned by Parallax Volatility Advisers
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Parallax Volatility Advisers
from 13F filings
Historical chart of Parallax Volatility Advisers investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Parallax Volatility Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Parallax Volatility Advisers
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $351k | 5.6k | 62.60 |
2023-09-30 | $3.8M | 84k | 45.39 |
2023-06-30 | $4.3M | 77k | 56.14 |
2023-03-31 | $4.7M | 104k | 45.23 |
2022-12-31 | $1.9M | 46k | 40.65 |
2022-09-30 | $6.8M | 103k | 65.35 |
2022-06-30 | $6.6M | 109k | 60.81 |
2022-03-31 | $3.6M | 57k | 62.76 |
2021-12-31 | $27M | 336k | 80.00 |
2021-09-30 | $33M | 303k | 110.00 |
2021-06-30 | $34M | 214k | 160.00 |
2021-03-31 | $13M | 104k | 121.84 |
More positions owned by Parallax Volatility Advisers
View all positions for Parallax Volatility Advisers